Nigel Mackman
Nigel Mackman publishes mostly in Hematology, Molecular Biology and Immunology, on topics such as Blood Coagulation and Thrombosis Mechanisms, Venous Thromboembolism Diagnosis and Management and Platelet Disorders and Treatments.
- World rank
- #43,227 of 7,710,434 ranked researchers
- Rank in United States
- #16,620 of 1,627,098
- Works
- 833
- Citations
- 56k
- Citations per work
- 66.8
What does Nigel Mackman research?
Nigel Mackman's work is mostly in Medicine (43%), Biochemistry, Genetics and Molecular Biology (9%), Immunology and Microbiology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences35742.8%
- Medicine35742.8%
- Everything else32739.2%
- Life Sciences15018.0%
- 1Hematology25% of their works
- 2Molecular Biology9% of their works
- 3Immunology9% of their works
- 4Internal Medicine7% of their works
- 5Cardiology and Cardiovascular Medicine6% of their works
- 6Genetics5% of their works
Research topics
- Blood Coagulation and Thrombosis Mechanisms
- Venous Thromboembolism Diagnosis and Management
- Platelet Disorders and Treatments
- Hemophilia Treatment and Research
- Extracellular vesicles in disease
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Protease and Inhibitor Mechanisms
- Cell Adhesion Molecules Research
Which keywords describe Nigel Mackman's research?
The keywords of their largest research topics: Antithrombotic Therapy, Inflammation, Hemostasis, Protease-Activated Receptors, Thrombin, Prophylaxis, Pulmonary Embolism and Venous Thromboembolism.
- Tissue Inhibitors of Metalloproteinases
- Integrins
- Kinin Receptor Family
- Extracellular Vesicles
- Hemophilia
- Platelets
- Extracellular Matrix
- Cancer
- Venous Thromboembolism
- Prophylaxis
- Protease-Activated Receptors
- Inflammation
- Antithrombotic Therapy
- Hemostasis
- Thrombin
- Pulmonary Embolism
- Thrombosis
- Angiogenesis
- Immune Thrombocytopenic Purpura
- Factor VIII
- Exosomes
- Hereditary Angioedema
- Cell Adhesion
- Matrix Metalloproteinases
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Antithrombotic Therapy5252 topics
- Inflammation4983 topics
- Hemostasis4462 topics
- Protease-Activated Receptors3641 topic
- Thrombin3641 topic
- Prophylaxis2422 topics
- Pulmonary Embolism1611 topic
- Venous Thromboembolism1611 topic
- Thrombosis1552 topics
- Cancer1272 topics
- Angiogenesis1042 topics
- Extracellular Matrix1042 topics
- Immune Thrombocytopenic Purpura821 topic
- Platelets821 topic
- Factor VIII811 topic
- Hemophilia811 topic
- Exosomes751 topic
- Extracellular Vesicles751 topic
- Hereditary Angioedema731 topic
- Kinin Receptor Family731 topic
- Cell Adhesion521 topic
- Integrins521 topic
- Matrix Metalloproteinases521 topic
- Tissue Inhibitors of Metalloproteinases521 topic
Where does Nigel Mackman work?
Nigel Mackman's main affiliation in the publication record is University of North Carolina at Chapel Hill, United States.
How many publications and citations does Nigel Mackman have?
OpenAlex counts 833 works and 55,623 citations for Nigel Mackman, an h-index of 124, ranking #43,227 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Nigel Mackman
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Nigel Mackman. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.